Linde posted record second quarter 2026 results with sales of US$9.289 billion and net income of US$1.928 billion, alongside higher earnings per share compared to a year earlier. Despite these record figures and new long-term contracts in semiconductors and renewable power, the stock has pulled back 10.34% over the past 30 days, closing at $478.38. A widely followed narrative places Linde's fair value around $545.44, implying a 12.3% upside, supported by a project backlog that has doubled over four years and is anchored by long-term fixed-fee contracts in U.S. clean energy and electronics infrastructure. However, a simpler valuation lens shows Linde trading at a P/E of 31.2x, above the U.S. Chemicals industry average of 24.8x and an estimated fair ratio of 25.5x, suggesting less of a safety cushion if expectations slip. The mixed outlook leaves the next move an open question, with potential risks including weak European industrial demand or slower progress in clean energy and hydrogen adoption.
Linde plc Ordinary SharesRecord Q2 results and new contracts are positive, but high P/E and mixed outlook create uncertainty.